Wallet-friendly cards showing proof of COVID vaccinations served a purpose early in the pandemic, but they’re on their way out. The U.S. Centers for Disease Control and Prevention has stopped printing the cards, likely changing how people track their shots in the future. The cards people have at home can still be used as proof… read on > read on >
While many have raved about the powers of popular weight-loss drugs like Wegovy and Ozempic, new research confirms the medications can trigger some nasty gastrointestinal side effects. Known as GLP-1 agonists, they may increase the risk of stomach paralysis, pancreatitis and bowel obstruction, scientists found. “Although the incidence of these adverse events are relatively rare,… read on > read on >
U.S. cancer centers continue to have shortages of commonly used chemotherapy drugs, a new survey shows, though the medications are not as scarce as they were last June. The National Comprehensive Cancer Network (NCCN), a nonprofit alliance of leading cancer centers, surveyed its network in September. In all, 72% of cancer centers surveyed reported a… read on > read on >
A nasal spray containing a ketamine derivative appears to beat one of the standard drugs used for people with difficult-to-treat depression, a new clinical trial has found. The trial, of nearly 700 people with treatment-resistant depression, found that esketamine nasal spray was more effective at sending patients into remission than a standard oral drug called… read on > read on >
Moderna Inc. announced Wednesday that it has seen positive early results with a new vaccine that would guard against four strains of flu plus COVID-19. In interim findings from a Phase 1/2 trial, the vaccine showed both a strong immune response compared to the standard dose of flu vaccine in adults aged 50 to 64… read on > read on >
In the United States, “conversion therapy” for LGBTQ people has been widely condemned by major medical associations. Not only that, nearly half of the country has now banned the practice for minors. But a new review of 16 investigations across six nations suggests conversion therapy is hardly a thing of the past. On average, nearly… read on > read on >
While HDL cholesterol is considered the “good” kind for heart and brain health, too much or too little of it may up a person’s risk of dementia, new research suggests. “This study is especially informative because of the large number of participants and long follow-up,” noted study author Maria Glymour, of Boston University. She said… read on > read on >
America’s kids are safer now than a decade ago when it comes to many types of injury, with two glaring exceptions: drugs and guns. That’s the crux of a new study that looked at injury trends among U.S. children and teenagers between 2011 and 2021. It found that nonfatal injuries from accidents and assaults fell… read on > read on >
More than 80% of eligible Americans did not get a COVID-19 booster shot last fall. Now, a new study reveals the reasons for the hesitation. Nearly 40% of survey participants said a prior COVID-19 infection factored into their decision to not get the booster. Another 31.5% were worried about side effects. And an additional 28%… read on > read on >
Rates of diabetes in younger adults are rising globally — and it could be shortening life spans. A diagnosis of type 2 diabetes at age 30 can cut life expectancy by up to 14 years, according to findings from a new study. Even a diagnosis at age 50 can shorten life expectancy by six years.… read on > read on >
